These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29491080)

  • 1. Transitory Stoma at the Time of Complete Cytoreductive Surgery Affects Survival for Patients with Advanced-stage Ovarian Cancer.
    Canlorbe G; Touboul C; Chargari C; Bentivegna E; Maulard A; Pautier P; Genestie C; Morice P; Gouy S
    Anticancer Res; 2018 Mar; 38(3):1517-1523. PubMed ID: 29491080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative study of three different managements after colorectal anastomosis in ovarian cancer: conservative management, diverting ileostomy, and ghost ileostomy.
    Lago V; Sanchez-Migallón A; Flor B; Padilla-Iserte P; Matute L; García-Granero Á; Bustamante M; Domingo S
    Int J Gynecol Cancer; 2019 Sep; 29(7):1170-1176. PubMed ID: 31296558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of definitive stoma after surgery for peritoneal malignancy in 958 patients: comparative study between complete cytoreductive surgery and maximal tumor debulking.
    Riss S; Chandrakumaran K; Dayal S; Cecil TD; Mohamed F; Moran BJ
    Eur J Surg Oncol; 2015 Mar; 41(3):392-5. PubMed ID: 25238953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes after bowel surgery and ostomy formation at the time of debulking surgery for advanced-stage epithelial ovarian carcinoma.
    Gockley AA; Fiascone S; Hicks Courant K; Pepin K; Del Carmen M; Clark RM; Goldberg J; Horowitz N; Berkowitz R; Worley M
    Int J Gynecol Cancer; 2019 Mar; 29(3):585-592. PubMed ID: 30833444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rectosigmoidectomy and Douglas Peritonectomy in the Management of Serosal Implants in Advanced-Stage Ovarian Cancer Surgery: Survival and Surgical Outcomes.
    Erkilinç S; Karataşli V; Demir B; Çakir İ; Can B; Karadeniz T; Gökçü M; Sanci M
    Int J Gynecol Cancer; 2018 Nov; 28(9):1699-1705. PubMed ID: 30371561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indications and practice of diverting ileostomy after colorectal resection and anastomosis in ovarian cancer cytoreduction.
    Lago V; Fotopoulou C; Chiantera V; Minig L; Gil-Moreno A; Cascales-Campos PA; Jurado M; Tejerizo A; Padilla-Iserte P; Malune ME; Di Donna MC; Marina T; Sanchez-Iglesias JL; Chiva L; Olloqui A; Matute L; García-Granero A; Cárdenas-Rebollo JM; Domingo S
    Gynecol Oncol; 2020 Sep; 158(3):603-607. PubMed ID: 32571682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic and Predictive Value of the Peritoneal Cancer Index in Primary Advanced Epithelial Ovarian Cancer Patients After Complete Cytoreductive Surgery: Study of Tumor Bank Ovarian Cancer.
    Gasimli K; Braicu EI; Richter R; Chekerov R; Sehouli J
    Ann Surg Oncol; 2015 Aug; 22(8):2729-37. PubMed ID: 25672560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A radical approach to achieve complete cytoreductive surgery improve survival of patients with advanced ovarian cancer.
    Liberale G; Pop CF; Polastro L; Kerger J; Moreau M; Chintinne M; Larsimont D; Nogaret JM; Veys I
    J Visc Surg; 2020 Apr; 157(2):79-86. PubMed ID: 31837942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytoreduction (Peritonectomy Procedures) Combined with Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Advanced Ovarian Cancer: Retrospective Italian Multicenter Observational Study of 511 Cases.
    Di Giorgio A; De Iaco P; De Simone M; Garofalo A; Scambia G; Pinna AD; Verdecchia GM; Ansaloni L; Macrì A; Cappellini P; Ceriani V; Giorda G; Biacchi D; Vaira M; Valle M; Sammartino P
    Ann Surg Oncol; 2017 Apr; 24(4):914-922. PubMed ID: 27896512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Morbidity and reversal rate of ileostomy after bowel resection during Visceral-Peritoneal Debulking (VPD) in patients with stage IIIC-IV ovarian cancer.
    Tozzi R; Casarin J; Garruto-Campanile R; Majd HS; Morotti M
    Gynecol Oncol; 2018 Jan; 148(1):74-78. PubMed ID: 29169615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for permanent stoma after rectal cancer surgery with temporary ileostomy.
    Kim MJ; Kim YS; Park SC; Sohn DK; Kim DY; Chang HJ; Oh JH
    Surgery; 2016 Mar; 159(3):721-7. PubMed ID: 26490725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive and Prognostic Implication of Bowel Resections During Primary Cytoreductive Surgery in Advanced Epithelial Ovarian Cancer.
    Bartl T; Schwameis R; Stift A; Bachleitner-Hofmann T; Reinthaller A; Grimm C; Polterauer S
    Int J Gynecol Cancer; 2018 Nov; 28(9):1664-1671. PubMed ID: 30371563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diverting ileostomy during primary debulking surgery for ovarian cancer: Associated factors and postoperative outcomes.
    Tseng JH; Suidan RS; Zivanovic O; Gardner GJ; Sonoda Y; Levine DA; Abu-Rustum NR; Tew WP; Chi DS; Long Roche K
    Gynecol Oncol; 2016 Aug; 142(2):217-24. PubMed ID: 27261325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary cytoreductive surgery and adjuvant hormonal monotherapy in women with advanced low-grade serous ovarian carcinoma: Reducing overtreatment without compromising survival?
    Fader AN; Bergstrom J; Jernigan A; Tanner EJ; Roche KL; Stone RL; Levinson KL; Ricci S; Wethingon S; Wang TL; Shih IM; Yang B; Zhang G; Armstrong DK; Gaillard S; Michener C; DeBernardo R; Rose PG
    Gynecol Oncol; 2017 Oct; 147(1):85-91. PubMed ID: 28768570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of delayed interval cytoreductive surgery on the survival of patients with advanced stage high-grade epithelial ovarian carcinoma.
    Nasioudis D; Arevalo O; Gysler S; Ko EM; Cory L; Kim SH; Giuntoli RL; Latif NA
    Int J Gynecol Cancer; 2024 Jan; 34(1):131-137. PubMed ID: 38088174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer.
    Bogani G; Rossetti D; Ditto A; Martinelli F; Chiappa V; Mosca L; Leone Roberti Maggiore U; Ferla S; Lorusso D; Raspagliesi F
    J Gynecol Oncol; 2018 Sep; 29(5):e66. PubMed ID: 30022630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A restrictive stoma policy after colorectal anastomosis in ovarian cancer based on ghost ileostomy use.
    Lago V; Albert MM; Cruz MA; Guijarro Campillo RA; Padilla-Iserte P; Matute L; Gurrea M; Flor B; Domingo S
    Eur J Surg Oncol; 2024 Jun; 50(6):108325. PubMed ID: 38636248
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer.
    Bristow RE; Montz FJ; Lagasse LD; Leuchter RS; Karlan BY
    Gynecol Oncol; 1999 Mar; 72(3):278-87. PubMed ID: 10053096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A collaborative surgical approach to upper and lower abdominal cytoreductive surgery in ovarian cancer.
    Eng OS; Raoof M; Blakely AM; Yu X; Lee SJ; Han ES; Wakabayashi MT; Yuh B; Lee B; Dellinger TH
    J Surg Oncol; 2018 Jul; 118(1):121-126. PubMed ID: 29878375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abdominopelvic cytoreduction rates and recurrence sites in stage IV ovarian cancer: is there a case for thoracic cytoreduction?
    Perri T; Ben-Baruch G; Kalfon S; Beiner ME; Helpman L; Hogen LB; Shapira-Frommer R; Korach J
    Gynecol Oncol; 2013 Oct; 131(1):27-31. PubMed ID: 23880152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.